Nasdaq
$28.56▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $953.5MShares out 33.4M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
32- 8.20Pre-market26.08.20 13:15filedEFFECTOther#●●●#●●●
Yarrow Bioscience, Inc.
The registration statement filed by Yarrow Bioscience, Inc. was declared effective by the SEC on August 19, 2026. This effectiveness grants the company the legal authorization to issue and sell the securities detailed in the filing.…more
$28.56+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 8.17Pre-market26.08.15 10:32filedSCHEDULE 13GOwnership
Yarrow Bioscience, Inc.
ADAR1 Capital Management, LLC and Daniel Schneeberger entered into a joint filing agreement on August 14, 2026, regarding the Schedule 13G filing for Yarrow Bioscience, Inc. common stock. This agreement formalizes the joint reporting of their share ownership in the company.…more
$28.56+0.00%vs prev closeView filingShare - 8.13Regular26.08.13 23:00SCHEDULE 13G/AOwnership
Yarrow Bioscience, Inc.
Yarrow Bioscience, Inc. has filed a SCHEDULE 13G/A, reflecting an update in the beneficial ownership status reported by Zhang Xiaofan. This filing serves as an official disclosure regarding changes in the investor's significant shareholding.…more
$28.56+0.00%vs prev closeView filingShare
31 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 7.23After-hours26.07.24 05:26#●●●#●●●#●●●
VYNE, Yarrow와 합병 및 50대 1 액면병합 진행
VYNE Therapeutics는 Yarrow Bioscience와의 합병을 앞두고 특별 현금 배당을 지급했으며, 7월 24일 50대 1 비율의 액면병합을 시행합니다. 합병 완료 후 사명은 Yarrow Bioscience로 변경되며 나스닥에서 새로운 티커로 거래될 예정입니다.…more
$28.56+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS